For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Dr Reddy's Continues To Fall; Nomura Cuts Target Price

By Sunil
|

Shares in Dr Reddy's continued to decline in trade, as Nomura cut the target to Rs 4,346 from 4,919 rupees.

Dr Reddy's Continues To Fall; Nomura Cuts Target Price
The shares of the company have fallen in the last few trading sessions after a US FDA warning and reports that Lundin Law PC has announced that it is investigating claims against Dr Reddy's Laboratories concerning possible violations of federal securities laws.
 

Dr Reddy's recently said that it had received a warning letter for its plant in Srikakulam, Andhra pradesh and Miryalaguda in Telangana.

The oncology formulation facility in Vishakapatanam also received a similar warning. Dr Reddy's said that the warning was received for three of its plants in South India. These facilities were inspected in the months of Nov, 2014, Dec 2014 and Jan 2015. The company in a release said that it would actively engage with the agency to resolve the issues. "We have embarked on an initiative to revamp our quality system and processes", the company had said.

GoodReturns.in

Read more about: dr reddys nomura
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Find IFSC

We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more